US biopharma Biohaven has provided an update regarding the taldefgrobep alfa development programs in spinal muscular atrophy ...

Cassava Sciences, a US biotech developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, was ...

Positive top-line results from the Phase III ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for belantamab ...

The US Food and Drug Administration (FDA) has approved Imkeldi (imatinib) oral solution, the first oral liquid form of ...

Specialist preclinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has ...

Danish biotech Adcendo today announced the successful closing of an oversubscribed $135 million Series B financing round. The ...

Centauri Therapeutics secured a £1 million ($1.25 million) grant from PACE to advance its Alphamer technology, targeting ...

A patient in Neurogene’s ongoing Phase I/II trial for Rett syndrome—who was dosed on November 5 with 3E15 vg of NGN-401—has ...

Lexicon Pharmaceuticals is shifting focus to its late-stage pipeline following the FDA's rejection of Zynquista for type 1 ...

The US Food and Drug Administration (FDA) on Friday approved Attruby (acoramidis), an orally-administered near-complete (≥90% ...